FILING ANALYSIS · THURSDAY, OCTOBER 22
JANEL CORP JANL — 8-K: Entry into a Material Definitive Agreement
neutral
Janel Corporation acquired EnCor Biotechnology Inc. for $17 million, funded by cash, borrowings, and a subordinated promissory note, and amended its senior credit facility to increase the acquisition facility commitments by $15 million, with $11 million immediately funded by lenders.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →